Infirst Healthcare launches three new chocolate-flavored cough-cold items for kids
CVS Caremark announces new clinicial affiliations with four healthcare providers
WOONSOCKET, R.I. — CVS Caremark has entered into new clinical affiliations with four healthcare providers — ProHealth Physicians in Connecticut, Texas Health Resources in Texas, Palmetto Health in South Carolina and the Baton Rouge Clinic in Louisiana — to enhance access to healthcare services for patients, the company announced on Wednesday.
These new clinical affiliations bring the total number of health system and healthcare provider affiliations for CVS Caremark and MinuteClinic to 40 health systems and healthcare providers across the country.
Through these clinical affiliations the patients of these healthcare providers will receive access to clinical support, medication counseling, chronic disease monitoring and wellness programs at CVS/pharmacy stores and MinuteClinic. In addition, CVS Caremark will provide critical prescription and visit information to those healthcare providers through the integration of secured electronic medical record systems.
"We look forward to working with these healthcare providers to develop collaborative programs that improve patient outcomes, lower costs and help people on their path to better health," stated Troyen A. Brennan, chief medical officer, CVS Caremark. "Through these clinical affiliations, we will also be integrating our electronic medical records and information systems to enable us to support patients with medication counseling and chronic disease monitoring."
The participating healthcare providers will receive data on interventions conducted by CVS pharmacists to improve medication adherence for their patients. The affiliation also encourages collaboration between the healthcare providers and MinuteClinic providers to improve coordination of care for patients seen at MinuteClinic locations. Physicians affiliated with the participating healthcare providers will collaborate with MinuteClinic nurse practitioners to work closely on joint clinical programs and care coordination activities. If more comprehensive care is needed, patients can follow up with their primary care provider and have access to the services at the healthcare provider as appropriate.
For those patients who do not have regular access to health care, MinuteClinic provides assistance in finding a primary care physician and a greater opportunity for continuity of health care services.
"Finding cost-effective ways to increase access to care continues to be important, especially in this era of health care reform, and we are pleased to work together with these health care providers to help coordinate comprehensive care for their patients," added Brennan. "Many patients rely on their local pharmacist for information and support regarding their prescription medications and these affiliations enable CVS pharmacists to help improve affiliated health care providers' patient health outcomes through better medication adherence. MinuteClinic also plays an important role by providing patients with timely, affordable and high-quality walk-in health care."
MinuteClinic, CVS/pharmacy and the participating healthcare providers will begin to work toward integrating EMR systems to streamline communication around all aspects of each individual patient's care. This integration will include the electronic sharing of messages and alerts from CVS/pharmacy to the healthcare providers' physicians regarding potential medication non-adherence issues. In addition, MinuteClinic will electronically share medical histories and visit summaries with the patient's primary care provider when they are a member of a participating healthcare provider.
MinuteClinic will continue its standard practice of sending patient visit summaries to primary care providers who are not affiliated with one of these participating health care providers via fax or mail, typically within 24 hours, with patient consent.
Survey: Seniors support strong patient safeguards for biosimilar medications
- 92% wanted a requirement that drug companies test the safety of biosimilars for all conditions the drug will be used to treat;
- 86% wanted a requirement that drug companies that are developing biosimilars conduct human clinical trials to ensure a given biosimilar is safe;
- 90% believed that the name of the biosimilar should be different than the original biologic medicine to allow for adequate tracking of any adverse reactions;
- 91% want physicians to be notified when a biosimilar is substituted for the original biologic drug they prescribed for their patient; and
- 94% believe patients should be notified when a biosimilar is substituted for the original drug prescribed by their doctor.